Experimental Treatment of Ebola Virus Disease with Brincidofovir.
<h4>Background</h4>The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of age...
Saved in:
| Main Authors: | Jake Dunning, Stephen B Kennedy, Annick Antierens, John Whitehead, Iza Ciglenecki, Gail Carson, Rupa Kanapathipillai, Lyndsey Castle, Rebecca Howell-Jones, Raul Pardinaz-Solis, Jennifer Grove, Janet Scott, Trudie Lang, Piero Olliaro, Peter W Horby, RAPIDE-BCV trial team |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0162199&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.
by: Jake Dunning, et al.
Published: (2016-04-01) -
Evaluating clinical trial designs for investigational treatments of Ebola virus disease.
by: Ben S Cooper, et al.
Published: (2015-04-01) -
Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir
by: Yifan Zhang, et al.
Published: (2025-04-01) -
Disseminated Mpox infection, a rare case of an immunocompromised patient treated with tecovirimat and brincidofovir
by: Paytra A. Klein, MBA, et al.
Published: (2025-05-01) -
Comparison of Adverse Effects of Combination Therapy of Mpox With Tecovirimat and Brincidofovir, and Individual Therapy With Tecovirimat
by: Muhammad Affan Abid, et al.
Published: (2025-03-01)